Download PDF
Thromb Haemost 1984; 52(02): 218
DOI: 10.1055/s-0038-1661180
Letter to the Editor
Schattauer GmbH Stuttgart

Platelet Factor 3 Availability Induced by Phorbol-12-Myristate-13-Acetate

Zohara Jerushalmy
Rogoff-Wellcome Medical Research Institute, Tel-Aviv University Medical School, Beilinson Medical Center, Petah-Tikva 49100, Israel
,
Thalma Englender
*   Department of Haematology, Tel-Aviv University Medical School, Beilinson Medical Center, Petah-Tikva 49100, Israel
,
Matitiahu Shaklai
*   Department of Haematology, Tel-Aviv University Medical School, Beilinson Medical Center, Petah-Tikva 49100, Israel
› Author Affiliations
Further Information

Publication History

Received 05 July 1984

Accepted 24 July 1984

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Hecker E. Carcinogenic principles from the seed oil of Croton Tiglium and from other euphorbiaceae. Cancer Res 1968; 28: 2338-2349
    PubMedGoogle Scholar
  • 2 Goodwin BJ, Weinberg JB. Receptor-mediated modulation of human monocyte, neutrophil, lymphocyte and platelet function by phorbol diesters. J Clin Invest 1982; 70: 699-706
    CrossrefPubMedGoogle Scholar
  • 3 Zucker MB, Troll W, Belman S. The tumor promoter phorbol ester (12-0-tetradecanoylphorbol-13-acetate), a potent aggregating agent for blood platelets. J Cell Biol 1974; 60: 325-336
    CrossrefPubMedGoogle Scholar
  • 4 White JG, Rao GH R, Estensen RD. Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol 1974; 75: 301-314
    PubMedGoogle Scholar
  • 5 Spaet TH, Cintron J. Studies on platelet factor 3 availability. Br J Haematol 1965; 11: 269-275
    CrossrefPubMedGoogle Scholar
  • 6 Packard BS, Saxton MJ, Bissell MJ, Klein MP. Plasma membrane reorganization induced by tumor promoters in an epithelial cell line. Proc Natl Acad Sci 1984; 81: 449-452
    CrossrefPubMedGoogle Scholar